Inactive Provider
This provider's NPI has been deactivated on 04/16/2026. The information on this page is historical and may no longer be current.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,136 | 483 | 83.6% |
| Education | $1,992 | 3 | 16.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Arthrex, Inc. | $1,932 | 2 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $1,243 | 59 | $0 (2024) |
| Amgen Inc. | $1,043 | 47 | $0 (2024) |
| Janssen Biotech, Inc. | $993.40 | 48 | $0 (2024) |
| GlaxoSmithKline, LLC. | $844.37 | 50 | $0 (2023) |
| Genentech USA, Inc. | $584.70 | 27 | $0 (2019) |
| UCB, Inc. | $507.41 | 20 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $450.64 | 24 | $0 (2024) |
| Celgene Corporation | $429.27 | 24 | $0 (2019) |
| Lilly USA, LLC | $371.53 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,289 | 55 | Janssen Biotech, Inc. ($205.09) |
| 2023 | $1,405 | 56 | Amgen Inc. ($222.36) |
| 2022 | $1,242 | 52 | Janssen Biotech, Inc. ($164.96) |
| 2021 | $1,063 | 51 | Amgen Inc. ($215.10) |
| 2020 | $798.65 | 40 | Novartis Pharmaceuticals Corporation ($200.51) |
| 2019 | $1,398 | 68 | Novartis Pharmaceuticals Corporation ($228.34) |
| 2018 | $1,566 | 87 | Genentech USA, Inc. ($210.41) |
| 2017 | $3,368 | 77 | Arthrex, Inc. ($1,932) |
All Payment Transactions
486 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $39.11 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $9.30 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $30.95 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $34.02 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: Immunology and Neurology | ||||||
| 10/22/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $29.53 | General |
| Category: Inflammation | ||||||
| 10/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $30.34 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: ORTHOPEDICS | ||||||
| 10/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $40.56 | General |
| Category: Immunology | ||||||
| 09/26/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $21.51 | General |
| Category: Allergy/Immunology | ||||||
| 09/16/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $31.50 | General |
| Category: Immunology | ||||||
| 09/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: IMMUNOLOGY | ||||||
| 09/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Dermatology | ||||||
| 08/22/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Inflammation | ||||||
| 08/20/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: Immunology | ||||||
| 08/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: Immunology | ||||||
| 08/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $2.98 | General |
| Category: Immunology | ||||||
| 08/01/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: IMMUNOLOGY | ||||||
| 07/30/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Immunology and Neurology | ||||||
| 07/23/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: Immunology | ||||||
| 07/18/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $10.85 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,253 | 7,224 | $900,091 | $309,038 |
| 2022 | 22 | 1,147 | 6,464 | $902,158 | $306,132 |
| 2021 | 27 | 1,181 | 5,821 | $866,008 | $300,771 |
| 2020 | 28 | 1,244 | 6,578 | $946,245 | $290,746 |
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 273 | 1,631 | $298,473 | $166,264 | 55.7% |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | Office | 2023 | 26 | 237 | $78,210 | $23,814 | 30.4% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 57 | 349 | $99,465 | $23,811 | 23.9% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 51 | 430 | $78,213 | $12,210 | 15.6% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 29 | 238 | $40,936 | $9,638 | 23.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 23 | 171 | $38,817 | $9,565 | 24.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 64 | $16,000 | $9,515 | 59.5% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 29 | 150 | $37,500 | $7,636 | 20.4% |
| 64418 | Injection of anesthetic agent and/or steroid into suprascapular shoulder nerve | Office | 2023 | 18 | 71 | $31,237 | $6,736 | 21.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 18 | 19 | $23,237 | $6,383 | 27.5% |
| 76881 | Complete ultrasound scan of joint | Office | 2023 | 68 | 132 | $48,312 | $5,675 | 11.7% |
| 95957 | Measurement of brain wave activity (eeg), digital analysis | Office | 2023 | 18 | 19 | $16,948 | $4,701 | 27.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $10,400 | $4,546 | 43.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 199 | 378 | $3,402 | $3,136 | 92.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 52 | 228 | $16,644 | $2,772 | 16.7% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 18 | 19 | $7,904 | $2,064 | 26.1% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2023 | 14 | 127 | $6,096 | $1,445 | 23.7% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 15 | 15 | $5,685 | $1,444 | 25.4% |
| 92653 | Evaluation of brain response to sound for diagnosis of nervous system disorders with interpretation and report | Office | 2023 | 18 | 19 | $5,434 | $1,402 | 25.8% |
| 95930 | Measurement of nerve conduction using visual stimulation testing with report | Office | 2023 | 18 | 19 | $4,351 | $1,144 | 26.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 47 | 60 | $2,880 | $1,140 | 39.6% |
| 99421 | Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | Office | 2023 | 49 | 71 | $3,457 | $847.21 | 24.5% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 11 | 24 | $4,259 | $808.32 | 19.0% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2023 | 18 | 19 | $2,907 | $702.24 | 24.2% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 11 | 1,456 | $5,242 | $580.53 | 11.1% |
About Dr. Alexander Shikhman, M.D
Dr. Alexander Shikhman, M.D is a Rheumatology healthcare provider based in La Jolla, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417067893.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alexander Shikhman, M.D has received a total of $12,128 in payments from pharmaceutical and medical device companies, with $1,289 received in 2024. These payments were reported across 486 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($10,136).
As a Medicare-enrolled provider, Shikhman has provided services to 4,825 Medicare beneficiaries, totaling 26,087 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location La Jolla, CA
- Active Since 08/30/2006
- Last Updated 01/11/2026
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1417067893
Products in Payments
- Enbrel (Biological) $1,020
- COSENTYX (Biological) $926.99
- BENLYSTA (Biological) $844.37
- REMICADE (Biological) $497.90
- TREMFYA (Drug) $478.65
- Rituxan (Biological) $469.30
- EUFLEXXA (Device) $450.64
- Cimzia (Drug) $437.96
- Otezla (Drug) $429.27
- Hizentra (Biological) $350.06
- TALTZ (Drug) $265.98
- COSENTYX (Drug) $249.75
- FIRDAPSE (Drug) $214.60
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $196.99
- CUVITRU (Biological) $170.91
- Gamunex-C (Biological) $157.95
- XELJANZ (Drug) $150.38
- SAPHNELO (Biological) $142.12
- KEVZARA (Drug) $139.25
- OFEV (Drug) $132.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in La Jolla
Dennis Carson, Md, MD
Rheumatology — Payments: $310,762
Dr. Christina Payne, M.d, M.D
Rheumatology — Payments: $18,122
Dr. Stacey Schulman, M.d, M.D
Rheumatology — Payments: $16,449
Priya Reddy, Md, MD
Rheumatology — Payments: $13,262
Dr. Arnoldas Ceponis, Md, MD
Rheumatology — Payments: $12,315
Monica Guma, M.d., Ph.d, M.D., PH.D
Rheumatology — Payments: $10,363